NYSE:RYAN

KBW Raises Ryan Specialty Price Target to $55, Maintains Outperform

Keefe, Bruyette & Woods raised its price target on Ryan Specialty (NYSE: RYAN) to $55 from $49 while maintaining an Outperform rating.

Ryan Specialty shares are $48.10, up 3.2%.

The higher $55 target implies additional upside from the current share price and reflects a more constructive valuation view from analyst Meyer Shields.
Ryan Specialty Stock Rises 2.9% as Morgan Stanley Raises Price Target to $50

Ryan Specialty (NYSE: RYAN) shares are up about 2.9% after Morgan Stanley raised its price target on the specialty insurance company while maintaining an Overweight rating.

Morgan Stanley analyst Bob Huang increased the firm's price target to $50 from $48. Compared with the stock's current price of $42.42, the new target implies approximately 18% upside.

Ryan Specialty holds a strong position in the specialty insurance distribution market, providing wholesale brokerage and underwriting management services for complex or difficult-to-place risks. The company benefits from growing demand for specialty insurance as businesses face increasingly complex exposures that are often underserved by traditional insurance markets.

Its largely fee- and commission-based model also provides recurring revenue without assuming the same level of underwriting risk as an insurance carrier.

The 2.9% gain suggests investors are responding positively to Morgan Stanley's higher valuation outlook and reiterated Overweight rating, reinforcing confidence in Ryan Specialty's position within the growing specialty insurance sector.
Ryan Specialty Reports Robust Q3 2025 Growth with 25% Revenue Increase

Ryan Specialty Holdings (NYSE: RYAN) delivered strong third-quarter 2025 results, reporting total revenue of $754.6 million, up 24.8% year-over-year, driven by 15% organic growth and continued contributions from recent acquisitions.

Net income surged 118.6% to $62.6 million ($0.20 per share), while Adjusted EBITDAC climbed 23.8% to $235.5 million, with a margin of 31.2%. Adjusted net income rose 15.9% to $131.7 million, translating to adjusted EPS of $0.47, up 14.6% from the prior year.

Founder and Executive Chairman Patrick G. Ryan highlighted the firm’s ability to grow amid a challenging market, citing strong M&A integration, strategic investments in technology, and new talent acquisition. CEO Timothy W. Turner emphasized Ryan Specialty’s diversified product base and resilient business model, positioning the company for sustained industry-leading organic growth and long-term shareholder value.